This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3g9e
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 3g9e is ON HOLD Authors: Ruf, A., Benz, J., Bernardeau, A, Binggeli, A., Blum , D., Boehringer, M., Grether, U., Hilpert, H., Kuhn, B. , Maerki, H.P...) |
|||
| Line 3: | Line 3: | ||
The entry 3g9e is ON HOLD | The entry 3g9e is ON HOLD | ||
| - | Authors: | + | Authors: Benardeau, A. |
Description: Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes | Description: Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 11 11:10:57 2009'' |
Revision as of 09:10, 11 March 2009
Unreleased structure
The entry 3g9e is ON HOLD
Authors: Benardeau, A.
Description: Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes
Page seeded by OCA on Wed Mar 11 11:10:57 2009
